Acne Treatment Cream, Spot cream for Oily and Combination Skin, Visible Results in 21 Days, Blackhead Prevention, Gentle Fragrance Free Formula 35g (35g)

Show on Amazon

Offer

Product description

  • Precision acne treatment Eveellyn acne treatment soothes the redness and irritation caused by stubborn acne. Its gentle formula reduces swelling and discomfort while protecting sensitive skin. Designed for oily and combination skin, it maintains an optimal balance of oil and water without over-drying, and with continued use, it can make the skin clearer and more delicate. It is an ideal choice for acne-prone teenagers
  • Noticeable Improvement in 21 Days Apply morning and night to experience smoother, more even-toned skin. In week one, active blemishes calm; by day 14, texture shows visible refinement; and by week three, pores appear tightened and skin naturally radiant. Results improve over time with continued use of our acne cream
  • Gentle Skincare Routine This spot cream is free from fragrances and dyes, offering soothing hydration suitable for all genders. Apply SPF 30+ sunscreen after daytime use to protect delicate skin from UV-related issues. At night, the cream supports natural overnight renewal. Reapply sunscreen generously after prolonged sun exposure
  • Four-Step Skincare System Start with a mild cleanser and toner. Then, using clean fingers or a cotton swab, apply a pea-sized drop precisely onto blemishes. Follow with a non-comedogenic moisturizer as needed to maintain hydration. For best results, use nightly to enhance skin renewal
  • Eveellyn Tip During initial use, you may experience a mild detox reaction as plant-derived actives accelerate cell turnover. This effect typically subsides within 14 days. We recommend continuing use for 21 days to fully regulate sebum production. If you experience persistent discomfort or are unhappy for any reason, please contact our support team we ll provide a tailored solution for you

You might also be interested in these pimple creams.

© 2025 WHICH.ONE. ALL CONTENT IS SUBJECT TO OUR COPYRIGHT.